Nationwide & International
Patent practice before the USPTO is federal. From Carefree, Arizona, Knechtel Law Group advises medical device companies across the country's medtech hubs, and companies abroad bringing devices to the U.S. market.
United States
Knechtel Law Group represents medical device companies before the USPTO nationwide from Carefree, Arizona. Atlanta teams bridging engineering and clinical medicine can work with a patent attorney who has trained in both.
Austin device startups often draw as much on software and electronics talent as on clinical research. Robert Knechtel, a registered patent attorney who is also a physician and engineer, helps those teams claim what is inventive about their technology in terms that survive examination and later diligence.
Greater Boston device companies often begin with an invention licensed out of a hospital or university and grow up next to far larger competitors. Patent strategy here has to account for both facts from the first filing.
Knechtel Law Group represents medical device companies before the USPTO nationwide from Carefree, Arizona. For Chicago founders and in-house teams, that means patent counsel who reads the clinical problem, the engineering, and the claims together.
Many Northeast Ohio device companies begin inside a hospital or research lab, which makes licensing terms and inventorship as important as the claims themselves. Robert Knechtel, a patent attorney, physician and engineer, helps founders build patent positions around clinically originated technology.
North Texas device companies often compete in mature categories such as ophthalmic surgery and spine, where established portfolios define the terrain. Robert Knechtel, a registered patent attorney with medical and engineering training, helps teams find protectable ground and move through examination with purpose.
Front Range device companies often pair hardware, single-use disposables and control software in one system. Robert Knechtel, a registered patent attorney with medical and engineering training, helps teams protect each layer of that system deliberately.
Houston device companies frequently begin inside a hospital system, with clinician inventors, institutional partners and long clinical programs. Robert Knechtel, a registered patent attorney who is also a physician and engineer, helps those teams sort out ownership early and plan a portfolio that lasts through regulatory review.
Greater Los Angeles has a long history in implantable electronics and drug delivery, and a growing share of new device ideas now come from its academic medical centers. Each path brings its own patent questions.
Memphis device companies inherit nearly a century of orthopedic manufacturing know-how, along with the dense patent landscape that comes with it. Robert Knechtel, a patent attorney, physician and engineer, helps founders protect spine, extremity and trauma innovations while keeping patent and regulatory positions consistent.
South Florida's device sector spans interventional cardiology, diagnostics, neural interfaces and vision care, often with an eye toward international markets. Robert Knechtel, a patent attorney, physician and engineer, helps founders protect clinical-stage technology and plan filings beyond the United States.
In Minnesota's Medical Alley, a new device company is frequently founded by engineers who learned the trade at an established one. That history makes prior art, prior employers, and clean ownership central to patent planning.
Nashville founders often build devices at the intersection of engineering, software and care delivery, where patent eligibility and early disclosure questions arise quickly. Robert Knechtel, a patent attorney, physician and engineer, helps these companies turn technical work into defensible patent assets.
Knechtel Law Group represents medical device companies before the USPTO nationwide from Carefree, Arizona. Companies on both sides of the Hudson can work with a patent attorney who is also a physician and engineer, without regard to where the firm sits.
Orange County has deep concentrations in catheter-based cardiovascular, neurovascular, and ophthalmic devices. Companies entering those fields meet large, mature patent portfolios almost immediately.
Knechtel Law Group represents medical device companies before the USPTO nationwide from Carefree, Arizona. Philadelphia-area teams can work directly with a patent attorney trained in medicine and engineering on claims that match how their devices are actually used.
Knechtel Law Group is based in Carefree, Arizona. Robert Knechtel, a registered patent attorney who is also a physician and engineer, works with device companies whose products depend on electronics, sensors and precision manufacturing.
Knechtel Law Group represents medical device companies before the USPTO nationwide from Carefree, Arizona. Pittsburgh teams working at the edge of robotics, biomaterials, and artificial organs can work with a patent attorney who is also a physician and engineer.
Knechtel Law Group represents medical device companies before the USPTO nationwide from Carefree, Arizona. Triangle founders moving technology out of Duke, UNC, or NC State can work with a patent attorney who brings clinical and engineering training to the claims.
Wasatch Front device teams work in some of the most densely patented corners of medicine, from catheters to implanted neural interfaces. Robert Knechtel, a registered patent attorney who is also a physician and engineer, helps founders and in-house teams build claims that hold up in that environment.
Several of San Diego's best-known device companies sell hardware that works together with software, apps, or cloud services. Protecting that kind of product takes claims written for the whole system, not just the device in hand.
Bay Area device companies tend to move quickly from clinical need to prototype to venture financing. A patent program that keeps pace with that schedule, and holds up when an acquirer reviews it, is worth planning early.
The Seattle region's device industry grew from ultrasound and emergency care, and many of its startups are founded by engineers who left established companies. Robert Knechtel, a patent attorney, physician and engineer, helps these teams secure clean ownership and claims that stand apart in mature technical fields.
Indiana device companies compete in some of the most heavily patented territory in medicine: joint reconstruction, trauma, and the instruments that go with them. Robert Knechtel, a patent attorney who is also a physician and engineer, advises founders and technical leaders on building patent positions that hold up in that environment.
International
Start with U.S. patent strategy for international medical device companies, then your country:
Australian device companies typically look offshore early because the home market is modest in size. The U.S. portfolio often ends up being the most valuable part of the patent estate, and it deserves to be planned that way from the first filing.
For many Canadian device companies, the United States is the first export market and sometimes the main one. The closeness of the two systems makes it easy to overlook the timing and inventorship differences that shape a sound U.S. portfolio.
For device companies based in China, the U.S. patent plan starts before the first U.S. filing, because Chinese law governs when an invention developed in China may be filed abroad. From there, the portfolio has to be rebuilt for a system with no utility models and a different view of prior disclosures.
French device companies often build their patent estate around INPI and the European system, including the Unitary Patent. Adding a strong U.S. portfolio means working within French filing rules while taking advantage of the more forgiving U.S. treatment of early disclosures.
German device makers often arrive in the United States with a mature European portfolio and a CE-marked product. The U.S. market asks for a separate patent position, built on U.S. law and timed to the FDA pathway.
Irish device companies grow up in one of the world's densest medtech ecosystems, and many look to the United States early. A U.S. patent strategy should be built for that market on its own terms.
For many Israeli device companies, the United States is the first major commercial market and the place where acquirers and investors judge the portfolio. The U.S. patent position deserves the same rigor as the FDA plan.
Japanese device makers often arrive in the United States with a mature home portfolio built for the JPO and PMDA. Carrying that work into the U.S. market takes a deliberate plan for filing sequence, claim scope, and launch risk.
Dutch device companies often start from a strong technology base and a European patent plan. Entering the United States calls for a separately examined, separately enforced U.S. portfolio.
Korean device companies frequently build strong KIPO portfolios before looking to the United States. A U.S. plan should decide early which inventions justify U.S. protection and how those claims will hold up against U.S. competitors.
Swiss device companies are navigating a changing relationship with the EU market while planning for FDA. A deliberate U.S. patent position helps make the U.S. launch an asset rather than an exposure.
UK device companies are building for three distinct systems at once: Great Britain, Europe and the United States. The U.S. patent position should be planned as its own workstream, not an afterthought to the European filing.